Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000919574-24-005846
Filing Date
2024-10-11
Accepted
2024-10-11 11:08:34
Documents
1
Effectiveness Date
2024-10-11
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6340
  Complete submission text file 0000919574-24-005846.txt   7581
Mailing Address 3000 SAND HILL ROAD BUILDING 3, SUITE 150 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 3, SUITE 150 MENLO PARK CA 94025 650-681-8482
Sofinnova BioEquities Enhanced Master Fund, LP (Filer) CIK: 0001949475 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-461670 | Film No.: 241366727